Hayat Biotech, a UAE-based biotechnology business, showed interest in collaborating and investing in the digitalization of Pakistan’s health sector on Tuesday.
A group from Hayat Biotech and Sinopharm, led by Saboor Karamat, General Counsel of the UAE’s Sheikh Ahmed Dalmook Al-Maktoum, paid a visit to Prime Minister Shehbaz Sharif here.
Abdul Qadir Patel, Minister of National Health Services, and other top officials were also present during the meeting.
He praised Sheikh Ahmed Dalmook Al-keen Maktoum’s enthusiasm in collaborating and investing in Pakistan’s health industry.
During the discussion, it was revealed that the country’s yearly blood collection of 3 million liters was not properly utilized owing to a shortage of plasma fractionation facilities. Thousands of lives will be saved if a plasma fractionation plant is established in Pakistan by using all components to be separated from donated blood.
The prime minister instructed all necessary organizations to fully support the proposed project’s enterprises.
Previously, it was revealed that the United Arab Emirates (UAE) intends to spend one billion dollars in Pakistan’s commercial and investment sectors, according to an official source in Abu Dhabi.
The move is intended to explore new investment possibilities, increase bilateral economic connections, and strengthen mutual collaboration in projects across several sectors of the economy.